Target intelligence / Profile preview

Salmonella Typhi Vi capsular polysaccharide-specific B cell receptor (Vi-specific BCR)

Target
Vi-specific BCR
Molecular classification
Receptor, Other
01

Overview

The Salmonella Typhi Vi capsular polysaccharide-specific B cell receptor (BCR) is a membrane-bound immunoglobulin complex expressed on the surface of specific B lymphocytes. It plays a critical role in the adaptive immune recognition of Salmonella enterica serovar Typhi, the causative agent of typhoid fever. The Vi capsular polysaccharide is a major virulence factor of S. Typhi that shields the bacterium from complement deposition and phagocytosis. When vaccines containing the Vi antigen (either as a plain polysaccharide or conjugated to a carrier protein) are administered, they target these specific BCRs. Binding and cross-linking of the BCRs by the Vi antigen activate intracellular signaling cascades, leading to B cell proliferation, clonal expansion, and the production of protective anti-Vi antibodies.

Other names
Salmonella enterica serovar Typhi Vi capsular polysaccharide-specific B-cell receptorVi antigen-specific B-cell receptorVi capsular polysaccharide-specific B cell receptorVi-specific B-cell receptorVi-specific BCR
02

Mechanism of action

Vaccine antigens bind to and cross-link Vi capsular polysaccharide-specific B cell receptors on B lymphocytes, triggering receptor-mediated signaling, clonal expansion, and differentiation into antibody-secreting plasma cells and memory B cells to provide protective immunity against Salmonella Typhi.

03

Biological functions

Immune responseOther
04

Disease associations

Infection
05

Safety considerations

Hypersensitivity or anaphylactic reactions to vaccine componentsTransient local injection site reactions (pain, erythema, swelling)Mild systemic reactions (fever, headache, malaise)Hyporesponsiveness or limited immunological memory with repeated doses of unconjugated polysaccharide vaccines
06

Interacting drugs

Typhoid Vi capsular polysaccharide vaccine

5 more in the full profile.

07

Biomarkers

Anti-Vi IgG antibody titerAnti-Vi IgA antibody titerVi-specific plasmablast frequencyIGHV3-23 gene usage

Beyond the preview

Go deeper on Salmonella Typhi Vi capsular polysaccharide-specific B cell receptor (Vi-specific BCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella Typhi Vi capsular polysaccharide-specific B cell receptor (Vi-specific BCR).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call